Blaine Davis - Jan 3, 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Chief Financial Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
Stock symbol
RNAC
Transactions as of
Jan 3, 2025
Transactions value $
-$134,036
Form type
4
Date filed
1/7/2025, 08:04 PM
Previous filing
Jan 6, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Sale -$66.2K -3.96K -3.85% $16.72 98.8K Jan 3, 2025 Direct F1
transaction RNAC Common Stock Sale -$67.8K -4.03K -4.08% $16.83 94.8K Jan 6, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.